Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 383 entries
Sorted by: Best Match Show Resources per page
Neuroimaging studies of alexithymia: physical, affective, and social perspectives.

BioPsychoSocial medicine

Moriguchi Y, Komaki G.
PMID: 23537323
Biopsychosoc Med. 2013 Mar 28;7(1):8. doi: 10.1186/1751-0759-7-8.

Alexithymia refers to difficulty in identifying and expressing one's emotions, and it is related to disturbed emotional regulation. It was originally proposed as a personality trait that plays a central role in psychosomatic diseases. This review of neuroimaging studies...

Cite
Moriguchi Y, Komaki G. Neuroimaging studies of alexithymia: physical, affective, and social perspectives. Biopsychosoc Med. 2013;7(1):8doi: 10.1186/1751-0759-7-8.
Moriguchi, Y., & Komaki, G. (2013). Neuroimaging studies of alexithymia: physical, affective, and social perspectives. BioPsychoSocial medicine, 7(1), 8. https://doi.org/10.1186/1751-0759-7-8
Moriguchi, Yoshiya, and Komaki, Gen. "Neuroimaging studies of alexithymia: physical, affective, and social perspectives." BioPsychoSocial medicine vol. 7,1 (2013): 8. doi: https://doi.org/10.1186/1751-0759-7-8
Moriguchi Y, Komaki G. Neuroimaging studies of alexithymia: physical, affective, and social perspectives. Biopsychosoc Med. 2013 Mar 28;7(1):8. doi: 10.1186/1751-0759-7-8. PMID: 23537323; PMCID: PMC3621096.
Copy Download .nbib Format: NLM
Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects.

Evidence-based complementary and alternative medicine : eCAM

Galhena PB, Samarakoon SR, Thabrew MI, Weerasinghe GA, Thammitiyagodage MG, Ratnasooriya WD, Tennekoon KH.
PMID: 23243426
Evid Based Complement Alternat Med. 2012;2012:108626. doi: 10.1155/2012/108626. Epub 2012 Nov 13.

The present study investigated the anti-inflammatory effects of a polyherbal decoction comprised of Nigella sativa, Hemidesmus indicus, and Smilax glabra in order to justify its claimed antihepatocarcinogenic activity. Activation of hepatic nuclear factor-kappa B (NF-κB), IκB kinase (IKK α/β)...

Cite
Galhena PB, Samarakoon SR, Thabrew MI, et al. Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects. Evid Based Complement Alternat Med. 2012;2012:108626doi: 10.1155/2012/108626.
Galhena, P. B., Samarakoon, S. R., Thabrew, M. I., Weerasinghe, G. A., Thammitiyagodage, M. G., Ratnasooriya, W. D., & Tennekoon, K. H. (2012). Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects. Evidence-based complementary and alternative medicine : eCAM, 2012108626. https://doi.org/10.1155/2012/108626
Galhena, Prasanna B, et al. "Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects." Evidence-based complementary and alternative medicine : eCAM vol. 2012 (2012): 108626. doi: https://doi.org/10.1155/2012/108626
Galhena PB, Samarakoon SR, Thabrew MI, Weerasinghe GA, Thammitiyagodage MG, Ratnasooriya WD, Tennekoon KH. Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects. Evid Based Complement Alternat Med. 2012;2012:108626. doi: 10.1155/2012/108626. Epub 2012 Nov 13. PMID: 23243426; PMCID: PMC3517268.
Copy Download .nbib Format: NLM
The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial.

Iranian journal of microbiology

Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, Alikhani MY, Roshanaie G, Komaki S.
PMID: 26668706
Iran J Microbiol. 2015 Jun;7(3):173-7.

BACKGROUND AND OBJECTIVE: The aim of the study was to evaluate the clinical effects of a mouthwash containing Sage (Salvia officinalis) extracts on Streptococcus mutans (SM) causing dental plaque in school-aged children.MATERIAL AND METHODS: A double blind clinical trial...

Cite
Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, et al. The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iran J Microbiol. 2015;7(3):173-7
Beheshti-Rouy, M., Azarsina, M., Rezaie-Soufi, L., Alikhani, M. Y., Roshanaie, G., & Komaki, S. (2015). The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iranian journal of microbiology, 7(3), 173-7.
Beheshti-Rouy, Maryam, et al. "The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial." Iranian journal of microbiology vol. 7,3 (2015): 173-7.
Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, Alikhani MY, Roshanaie G, Komaki S. The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iran J Microbiol. 2015 Jun;7(3):173-7. PMID: 26668706; PMCID: PMC4676988.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A.

Genome announcements

Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y.
PMID: 26659677
Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01430-15.

Nonomuraea sp. TP-A0861 produces the nonribosomal peptide myxochelin A, which is known as a microbial siderophore. Here, we report its draft genome sequence. The genome contains at least three nonribosomal peptide synthetase gene clusters, one of which is proposed...

Cite
Komaki H, Ichikawa N, Hosoyama A, et al. Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01430-15.
Komaki, H., Ichikawa, N., Hosoyama, A., Fujita, N., & Igarashi, Y. (2015). Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01430-15
Komaki, Hisayuki, et al. "Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01430-15
Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y. Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01430-15. PMID: 26659677; PMCID: PMC4675942.
Copy Download .nbib Format: NLM
Seasonal variation in the chemical composition, antioxidant activity, and total phenolic content of Artemisia absinthium essential oils.

Pharmacognosy research

Mohammadi A, Sani TA, Ameri AA, Imani M, Golmakani E, Kamali H.
PMID: 26692746
Pharmacognosy Res. 2014 Oct-Dec;7(4):329-34. doi: 10.4103/0974-8490.158441.

BACKGROUND: The genus Artemisia belonging to the Compositae (Asteraceae) family and many traditional uses from the Artemisia species were reported. Artemisia absinthium is one of the species in this genus and commonly used in the food industry in the...

Cite
Mohammadi A, Sani TA, Ameri AA, et al. Seasonal variation in the chemical composition, antioxidant activity, and total phenolic content of Artemisia absinthium essential oils. Pharmacognosy Res. 2014;7(4):329-34doi: 10.4103/0974-8490.158441.
Mohammadi, A., Sani, T. A., Ameri, A. A., Imani, M., Golmakani, E., & Kamali, H. (2014). Seasonal variation in the chemical composition, antioxidant activity, and total phenolic content of Artemisia absinthium essential oils. Pharmacognosy research, 7(4), 329-34. https://doi.org/10.4103/0974-8490.158441
Mohammadi, A, et al. "Seasonal variation in the chemical composition, antioxidant activity, and total phenolic content of Artemisia absinthium essential oils." Pharmacognosy research vol. 7,4 (2014): 329-34. doi: https://doi.org/10.4103/0974-8490.158441
Mohammadi A, Sani TA, Ameri AA, Imani M, Golmakani E, Kamali H. Seasonal variation in the chemical composition, antioxidant activity, and total phenolic content of Artemisia absinthium essential oils. Pharmacognosy Res. 2014 Oct-Dec;7(4):329-34. doi: 10.4103/0974-8490.158441. PMID: 26692746; PMCID: PMC4660511.
Copy Download .nbib Format: NLM
Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients.

The open dentistry journal

Naganawa K, Takayama E, Adachi M, Mitsudo K, Iida M, Kamiya-Mizuno M, Kawaki H, Ichinose M, Motohashi M, Muramatsu Y, Tohnai I, Sumitomo S, Shikimori M, Kondoh N.
PMID: 25893021
Open Dent J. 2015 Mar 31;9:120-4. doi: 10.2174/1874210601509010120. eCollection 2015.

In order to evaluate the Th1 and Th2 responses of Oral Squamous Cell Carcinoma (OSCC) patients, we investigated the cytokine producing capability of peripheral blood (PB), and compared it with clinicopathological appearances of OSCC patients. The production of a...

Cite
Naganawa K, Takayama E, Adachi M, et al. Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients. Open Dent J. 2015;9:120-4doi: 10.2174/1874210601509010120.
Naganawa, K., Takayama, E., Adachi, M., Mitsudo, K., Iida, M., Kamiya-Mizuno, M., Kawaki, H., Ichinose, M., Motohashi, M., Muramatsu, Y., Tohnai, I., Sumitomo, S., Shikimori, M., & Kondoh, N. (2015). Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients. The open dentistry journal, 9120-4. https://doi.org/10.2174/1874210601509010120
Naganawa, Kosuke, et al. "Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients." The open dentistry journal vol. 9 (2015): 120-4. doi: https://doi.org/10.2174/1874210601509010120
Naganawa K, Takayama E, Adachi M, Mitsudo K, Iida M, Kamiya-Mizuno M, Kawaki H, Ichinose M, Motohashi M, Muramatsu Y, Tohnai I, Sumitomo S, Shikimori M, Kondoh N. Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients. Open Dent J. 2015 Mar 31;9:120-4. doi: 10.2174/1874210601509010120. eCollection 2015. PMID: 25893021; PMCID: PMC4397950.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces.

Genome announcements

Komaki H, Ichikawa N, Oguchi A, Hamada M, Tamura T, Fujita N.
PMID: 25657283
Genome Announc. 2015 Feb 05;3(1). doi: 10.1128/genomeA.01527-14.

Streptomyces albus is the type species of the genus Streptomyces. Here, we report the draft genome sequence of S. albus strain NBRC 13014(T). The genome contains at least seven orphan polyketide synthase and nonribosomal peptide synthetase gene clusters. The...

Cite
Komaki H, Ichikawa N, Oguchi A, et al. Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces. Genome Announc. 2015;3(1)doi: 10.1128/genomeA.01527-14.
Komaki, H., Ichikawa, N., Oguchi, A., Hamada, M., Tamura, T., & Fujita, N. (2015). Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces. Genome announcements, 3(1), . https://doi.org/10.1128/genomeA.01527-14
Komaki, Hisayuki, et al. "Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces." Genome announcements vol. 3,1 (2015). doi: https://doi.org/10.1128/genomeA.01527-14
Komaki H, Ichikawa N, Oguchi A, Hamada M, Tamura T, Fujita N. Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces. Genome Announc. 2015 Feb 05;3(1). doi: 10.1128/genomeA.01527-14. PMID: 25657283; PMCID: PMC4319605.
Copy Download .nbib Format: NLM
Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells.

Experimental and therapeutic medicine

Nagaya R, Mizuno-Kamiya M, Takayama E, Kawaki H, Onoe I, Tanabe T, Nagahara K, Kondoh N.
PMID: 24348757
Exp Ther Med. 2014 Jan;7(1):17-22. doi: 10.3892/etm.2013.1382. Epub 2013 Nov 06.

The mechanisms of immunomodulation by mesenchymal stromal cells remain poorly understood. In this study, the effects of mouse adipose tissue-derived mesenchymal stromal cells (ASCs) on mouse spleen cells alloreactively stimulated by anti-CD3 and anti-CD28 antibody-coated (anti-CD3/CD28) beads were observed....

Cite
Nagaya R, Mizuno-Kamiya M, Takayama E, et al. Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells. Exp Ther Med. 2013;7(1):17-22doi: 10.3892/etm.2013.1382.
Nagaya, R., Mizuno-Kamiya, M., Takayama, E., Kawaki, H., Onoe, I., Tanabe, T., Nagahara, K., & Kondoh, N. (2014). Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells. Experimental and therapeutic medicine, 7(1), 17-22. https://doi.org/10.3892/etm.2013.1382
Nagaya, Ryo, et al. "Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells." Experimental and therapeutic medicine vol. 7,1 (2014): 17-22. doi: https://doi.org/10.3892/etm.2013.1382
Nagaya R, Mizuno-Kamiya M, Takayama E, Kawaki H, Onoe I, Tanabe T, Nagahara K, Kondoh N. Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells. Exp Ther Med. 2014 Jan;7(1):17-22. doi: 10.3892/etm.2013.1382. Epub 2013 Nov 06. PMID: 24348757; PMCID: PMC3860983.
Copy Download .nbib Format: NLM
The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases.

Frontiers in oncology

Chi A, Nguyen NP, Komaki R.
PMID: 25009800
Front Oncol. 2014 Jun 25;4:151. doi: 10.3389/fonc.2014.00151. eCollection 2014.

Image guidance allows delivery of very high doses of radiation over a few fractions, known as stereotactic ablative radiotherapy (SABR). This treatment is associated with excellent outcome for early stage non-small cell lung cancer and metastases to the lungs....

Cite
Chi A, Nguyen NP, Komaki R. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol. 2014;4:151doi: 10.3389/fonc.2014.00151.
Chi, A., Nguyen, N. P., & Komaki, R. (2014). The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Frontiers in oncology, 4151. https://doi.org/10.3389/fonc.2014.00151
Chi, Alexander, et al. "The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases." Frontiers in oncology vol. 4 (2014): 151. doi: https://doi.org/10.3389/fonc.2014.00151
Chi A, Nguyen NP, Komaki R. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol. 2014 Jun 25;4:151. doi: 10.3389/fonc.2014.00151. eCollection 2014. PMID: 25009800; PMCID: PMC4070060.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin.

Genome announcements

Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y.
PMID: 26659684
Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01446-15.

Here, we report the draft genome sequence of Streptomyces sp. TP-A0356, a producer of a potent antitumor antibiotic, yatakemycin, to evaluate potential for secondary metabolite production. The genome sequence data suggest the presence of at least nine gene clusters...

Cite
Komaki H, Ichikawa N, Hosoyama A, et al. Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01446-15.
Komaki, H., Ichikawa, N., Hosoyama, A., Fujita, N., & Igarashi, Y. (2015). Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01446-15
Komaki, Hisayuki, et al. "Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01446-15
Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y. Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin. Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01446-15. PMID: 26659684; PMCID: PMC4675949.
Copy Download .nbib Format: NLM
Draft genome sequences of six type strains of the genus streptacidiphilus.

Genome announcements

Komaki H, Ichikawa N, Oguchi A, Hamada M, Tamura T, Fujita N.
PMID: 25573937
Genome Announc. 2015 Jan 08;3(1). doi: 10.1128/genomeA.01387-14.

Members of the genus Streptacidiphilus are acidophilic actinomycetes with streptomycete-like features. Here, we report the draft genome sequences of the type strains of Streptacidiphilus albus, Streptacidiphilus anmyonensis, Streptacidiphilus carbonis, Streptacidiphilus jiangxiensis, Streptacidiphilus melanogenes, and Streptacidiphilus neutrinimicus. These genome sequences...

Cite
Komaki H, Ichikawa N, Oguchi A, et al. Draft genome sequences of six type strains of the genus streptacidiphilus. Genome Announc. 2015;3(1)doi: 10.1128/genomeA.01387-14.
Komaki, H., Ichikawa, N., Oguchi, A., Hamada, M., Tamura, T., & Fujita, N. (2015). Draft genome sequences of six type strains of the genus streptacidiphilus. Genome announcements, 3(1), . https://doi.org/10.1128/genomeA.01387-14
Komaki, Hisayuki, et al. "Draft genome sequences of six type strains of the genus streptacidiphilus." Genome announcements vol. 3,1 (2015). doi: https://doi.org/10.1128/genomeA.01387-14
Komaki H, Ichikawa N, Oguchi A, Hamada M, Tamura T, Fujita N. Draft genome sequences of six type strains of the genus streptacidiphilus. Genome Announc. 2015 Jan 08;3(1). doi: 10.1128/genomeA.01387-14. PMID: 25573937; PMCID: PMC4290990.
Copy Download .nbib Format: NLM
A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl.

Breast cancer (Tokyo, Japan)

Sasa M, Morimoto T, Ii K, Tsuzuki H, Kamamura Y, Komaki K, Uyama T, Monden Y.
PMID: 11091535
Breast Cancer. 1995 Apr 30;2(1):71-75. doi: 10.1007/BF02966899.

We recently encountered a 6-year-old girl with a malignant phyllodes tumor of the breast. The patient's mother noticed a tumor on the right breast of her first doughter at 8 months after from her birth. The baby was brought...

Cite
Sasa M, Morimoto T, Ii K, et al. A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl. Breast Cancer. 1995;2(1):71-75doi: 10.1007/BF02966899.
Sasa, M., Morimoto, T., Ii, K., Tsuzuki, H., Kamamura, Y., Komaki, K., Uyama, T., & Monden, Y. (1995). A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl. Breast cancer (Tokyo, Japan), 2(1), 71-75. https://doi.org/10.1007/BF02966899
Sasa, et al. "A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl." Breast cancer (Tokyo, Japan) vol. 2,1 (1995): 71-75. doi: https://doi.org/10.1007/BF02966899
Sasa M, Morimoto T, Ii K, Tsuzuki H, Kamamura Y, Komaki K, Uyama T, Monden Y. A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl. Breast Cancer. 1995 Apr 30;2(1):71-75. doi: 10.1007/BF02966899. PMID: 11091535.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 383 entries